EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

65 hedge funds and large institutions have $31.9M invested in Eagle Pharmaceuticals, Inc. in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-10
Holders Change %
-13.33%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
11
Reduced
28
Closed
21
Calls
$3.74M
Puts
$4K
Net Calls
+$3.73M
Net Calls Change
-$1.93M

Top Buyers

1
NCM
Nantahala Capital Management
Connecticut
+$1.47M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$453K
3
USPCM
Union Square Park Capital Management
New York
+$212K
4
A
AJOVista
Massachusetts
+$169K
5
Marshall Wace
Marshall Wace
United Kingdom
+$104K

Top Sellers

1
LSV Asset Management
LSV Asset Management
Illinois
-$1.65M
2
AQR Capital Management
AQR Capital Management
Connecticut
-$1.2M
3
Bank of America
Bank of America
North Carolina
-$1.02M
4
PA
Perceptive Advisors
New York
-$971K
5
Millennium Management
Millennium Management
New York
-$940K
Name Holding Trade Value Shares
Change 		Shares
Change %
NCM
1
Nantahala Capital Management
Connecticut
$8.79M +$1.47M +394,466 +20%
ACM
2
AIGH Capital Management
Maryland
$4.52M – – –
Citigroup
3
Citigroup
New York
$3.73M -$4.35K -1,166 -0.1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.16M +$56.4K +15,111 +3%
AQR Capital Management
5
AQR Capital Management
Connecticut
$1.4M -$1.2M -321,805 -46%
BlackRock
6
BlackRock
New York
$1M -$316K -84,593 -24%
Renaissance Technologies
7
Renaissance Technologies
New York
$956K +$45.1K +12,100 +5%
Marshall Wace
8
Marshall Wace
United Kingdom
$833K +$104K +27,878 +14%
Morgan Stanley
9
Morgan Stanley
New York
$717K -$404K -108,235 -36%
Two Sigma Advisers
10
Two Sigma Advisers
New York
$690K -$148K -39,759 -18%
Assenagon Asset Management
11
Assenagon Asset Management
Luxembourg
$685K -$6.51K -1,745 -0.9%
JGC
12
J. Goldman & Co
New York
$562K -$151K -40,500 -21%
RC
13
RBF Capital
California
$534K +$55.9K +14,991 +12%
Jacobs Levy Equity Management
14
Jacobs Levy Equity Management
New Jersey
$453K +$453K +121,559 New
Two Sigma Investments
15
Two Sigma Investments
New York
$445K -$54.6K -14,632 -11%
TCM
16
Tang Capital Management
California
$443K – – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
$395K -$8.05K -2,158 -2%
Invesco
18
Invesco
Georgia
$309K +$1.31K +351 +0.4%
DCM
19
DGS Capital Management
New Jersey
$268K +$83K +22,239 +45%
USPCM
20
Union Square Park Capital Management
New York
$212K +$212K +56,963 New
A
21
AJOVista
Massachusetts
$211K +$169K +45,206 +402%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$204K -$434K -116,383 -68%
Bank of America
23
Bank of America
North Carolina
$190K -$1.02M -274,513 -84%
Deutsche Bank
24
Deutsche Bank
Germany
$182K – – –
TI
25
Trexquant Investment
Connecticut
$163K -$34.4K -9,230 -17%
1
2 3 4